Valuation Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:52 2026-07-22 EDT			5-day change	1st Jan Change
2,480.95 ^INR	-4.84%		-6.66%	+34.75%

05-14	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
05-14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	188,581	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	23.89%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	188,581	188,581	188,581
Change	-	68.55%	-12.11%	120.88%	52.16%	23.89%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	26.4x	23.2x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.28x	3.89x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.7x	1.7x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.58x	6.72x
EV / Revenue	0x	0x	0x	0x	0x	8.86x	7.58x	6.72x
EV / EBITDA	0x	0x	0x	0x	0x	25.4x	21.9x	19.2x
EV / EBIT	0x	0x	0x	-	0x	24.3x	20.2x	17.5x
EV / FCF	0x	0x	0x	0x	0x	49.6x	34.3x	34.8x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.92%	2.87%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.16%	0.16%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,480.95	2,480.95	2,480.95
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	5/6/21	5/12/22	5/27/23	5/16/24	5/15/25	5/14/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	32.15x	-	-	-	2.06B
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.82x	6.78x	23.42x	0.81%	48.88B
OTSUKA HOLDINGS CO., LTD.	18.26x	2.07x	9.71x	1.31%	35.72B
CIPLA LIMITED	27.54x	3.41x	17.43x	0.86%	12.02B
ZYDUS LIFESCIENCES LIMITED	27.1x	3.99x	16.26x	0.58%	11.84B
KRKA, D. D.	18.96x	3.31x	11.89x	3.51%	8.95B
ONO PHARMACEUTICAL CO., LTD.	15.88x	2.04x	6.86x	3.27%	6.91B
GEDEON RICHTER	8.23x	1.93x	5.05x	5.27%	6.78B
GLENMARK PHARMACEUTICALS LIMITED	34.03x	3.88x	16.49x	0.24%	6.57B
Average	24.22x	3.42x	13.39x	1.98%	15.52B
Weighted average by Cap.	26.34x	4.18x	15.91x	1.42%